Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 for advanced gastric cancer that is refractory to S-1 or S-1 plus CDDP: OGSG0701

被引：0
|
作者：
Tomono Kawase
Hiroshi Imamura
Masahiro Goto
Yutaka Kimura
Shugo Ueda
Jin Matsuyama
Kazuhiro Nishikawa
Naotoshi Sugimoto
Junya Fujita
Takao Tamura
Norimasa Fukushima
Hisato Kawakami
Daisuke Sakai
Yukinori Kurokawa
Toshio Shimokawa
Taroh Satoh
机构：
[1] Toyonaka Municipal Hospital,Department of Surgery
[2] Osaka Medical College Hospital,Cancer Chemotherapy Center
[3] Kinki University,Department of Surgery, Faculty of Medicine
[4] Kitano Hospital,Department of Gastroenterological Surgery
[5] Higashiosaka City Medical Center,Department of Gastroenterological Surgery
[6] Osaka General Medical Center,Department of Surgery
[7] Osaka International Cancer Institute,Department of Medical Oncology
[8] Sakai City Medical Center,Department of Surgery
[9] Kindai University,Department of Medical Oncology, Faculty of Medicine
[10] Yamagata Prefectural Central Hospital,Department of Surgery
[11] Osaka University Graduate School of Medicine,Department of Frontier Science for Cancer and Chemotherapy
[12] Osaka University Graduate School of Medicine,Department of Gastroenterological Surgery
[13] Wakayama Medical University,Clinical Study Support Center
来源：
International Journal of Clinical Oncology | 2021年 / 26卷
关键词：
Gastric cancer; Second-line chemotherapy; Paclitaxel; Irinotecan; S-1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1871 / 1880
页数：9
相关论文
共 50 条
  • [21] A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer
    Ueno, M.
    Okusaka, T.
    Omuro, Y.
    Isayama, H.
    Fukutomi, A.
    Ikeda, M.
    Mizuno, N.
    Fukuzawa, K.
    Furukawa, M.
    Iguchi, H.
    Sugimori, K.
    Furuse, J.
    Shimada, K.
    Ioka, T.
    Nakamori, S.
    Baba, H.
    Komatsu, Y.
    Takeuchi, M.
    Hyodo, I.
    Boku, N.
    ANNALS OF ONCOLOGY, 2016, 27 (03) : 502 - 508
  • [22] Phase II study of bi-weekly CPT-11+CDDP for patients with gastric cancer refractory to S-1 (OGSG 0504 study)
    Nakae, S.
    Hirao, M.
    Kishimoto, T.
    Iijima, S.
    Ishida, H.
    Morimoto, T.
    Imano, M.
    Goto, M.
    Uedo, N.
    Fujita, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [23] RANDOMIZED PHASE II TRIAL OF S-1 VERSUS S-1 PLUS OXALIPLATIN (SOX) IN PATIENTS WITH GEMCITABINE REFRACTORY PANCREATIC CANCER
    Okusaka, T.
    Ohkawa, S.
    Isayama, H.
    Fukutomi, A.
    Yamaguchi, K.
    Ikeda, M.
    Funakoshi, A.
    Nagase, M.
    Nakamori, S.
    Hamamoto, Y.
    ANNALS OF ONCOLOGY, 2012, 23 : 241 - 242
  • [24] Neoadjuvant chemotherapy with S-1 and CDDP in advanced gastric cancer
    Kochi, Mitsugu
    Fujii, Masashi
    Kanamori, Noriaki
    Kaiga, Teruo
    Takahashi, Toru
    Kobayashi, Michiyo
    Takayama, Tadatoshi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2006, 132 (12) : 781 - 785
  • [25] Randomized phase II trial of S-1 plus irinotecan versus S-1 plus paclitaxel as first-line treatment for advanced gastric cancer (OGSG0402): Final report
    Kishimoto, T.
    Imamura, H.
    Uedou, F.
    Fujitani, K.
    Iijima, S.
    Takiuchi, H.
    Imano, M.
    Shimokawa, T.
    Kurokawa, Y.
    Furukawa, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] A randomized phase III study of S-1 alone versus S-1 plus immunomodulator lentinan for unresectable or recurrent gastric cancer (JFMC36-0701)
    Nishikawa, K.
    Yoshino, S.
    Morita, S.
    Takahashi, T.
    Sakata, K.
    Nagao, J.
    Nemoto, H.
    Murakami, N.
    Matsuda, T.
    Hasegawa, H.
    Shimizu, R.
    Yoshikawa, T.
    Osanai, H.
    Imano, M.
    Naitoh, H.
    Yabe, M.
    Tanaka, A.
    Sakamoto, J.
    Saji, S.
    Oka, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S442 - S442
  • [27] Neoadjuvant chemotherapy with S-1 and CDDP in advanced gastric cancer
    Mitsugu Kochi
    Masashi Fujii
    Noriaki Kanamori
    Teruo Kaiga
    Toru Takahashi
    Michiyo Kobayashi
    Tadatoshi Takayama
    Journal of Cancer Research and Clinical Oncology, 2006, 132 : 781 - 785
  • [28] Adjuvant Chemotherapy With S-1 Plus Docetaxel Versus S-1 Plus Oxaliplatin in Stage III Gastric Cancer
    Yamamoto, Masaaki
    Omori, Takeshi
    Shinno, Naoki
    Hara, Hisashi
    Mukai, Yosuke
    Sugase, Takahito
    Takeoka, Tomohira
    Mikamori, Manabu
    Kanemura, Takashi
    Hasegawa, Shinichiro
    Akita, Hirofumi
    Haraguchi, Naotsugu
    Nishimura, Junichi
    Wada, Hiroshi
    Matsuda, Chu
    Yasui, Masayoshi
    Miyata, Hiroshi
    Ohue, Masayuki
    ANTICANCER RESEARCH, 2023, 43 (11) : 5015 - 5024
  • [29] Randomized phase III study of S-1 plus oxaliplatin versus S-1 plus cisplatin for first-line treatment of advanced gastric cancer
    Higuchi, Katsuhiko
    Koizumi, Wasaburo
    Yamada, Yasuhide
    Nishikawa, Kazuhiro
    Gotoh, Masahiro
    Fuse, Nozomu
    Sugimoto, Naotoshi
    Nishina, Tomohiro
    Amagai, Kenji
    Chin, Keisho
    Niwa, Yasumasa
    Negoro, Yuji
    Imamura, Hiroshi
    Tsuda, Masahiro
    Yasui, Hirotumi
    Fujii, Hirofumi
    Yamaguchi, Kensei
    Yasui, Hisateru
    Hamada, Chikuma
    Hyodo, Ichinosuke
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [30] Combination chemotherapy of S-1, docetaxel and CDDP for the treatment of advanced gastric cancer
    Niitsu, Yoshiro
    Takayama, Tetsuji
    Sato, Yasushi
    Sagawa, Tamotsu
    Abe, Seichiro
    Kato, Junji
    ANNALS OF ONCOLOGY, 2006, 17 : 313 - 314
12345